Recent developments in texaphyrin chemistry and drug discovery. - Wikidata - awgldk - TriplyDB

Recent developments in texaphyrin chemistry and drug discovery.

Recent developments in texaphyrin chemistry and drug discovery.

http://www.wikidata.org/entity/Q37659410

about

Gadolinium-based nanoparticles for theranostic MRI-radiosensitization Texaphyrins and water-soluble zinc(II) ionophores: development, mechanism of anticancer activity, and synergistic effects The first water coordination sphere of lanthanide(iii) motexafins (Ln-Motex2+, Ln = La, Gd, Lu) and its effects on structures, reduction potentials and UV-vis absorption spectra. Theoretical studies.Quantum chemical study of the autoxidation of ascorbate.Unprecedented rearrangement of diketopyrrolopyrroles leads to structurally unique chromophores.Hexaphyrin as a Potential Theranostic Dye for Photothermal Therapy and 19 F Magnetic Resonance Imaging.Metalated Hexaphyrins: From Understanding to Rational Design.

P2860

Q27027308-EB1B8B09-FA95-436C-B72B-1A70CF789466 Q30858160-7E722934-4B22-4441-8667-EAC91E599BB5 Q38670571-5CEDA75F-F16D-4440-9F76-132C0547EECD Q39674327-16B74970-32DE-475A-BE26-80DFEB48CC33 Q48172359-804F8CED-6DFD-4034-9036-754222B49D79 Q48235253-0DFADD1C-50E5-4A0B-8713-5BC3F3B72A9D Q53487651-EE5DC346-3440-42F3-A6B8-C51B26342E00

P2860

Recent developments in texaphyrin chemistry and drug discovery.

http://www.wikidata.org/entity/Q37659410

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 April 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Recent developments in texaphyrin chemistry and drug discovery.

@en

Recent developments in texaphyrin chemistry and drug discovery.

@nl

type

label

Recent developments in texaphyrin chemistry and drug discovery.

@en

Recent developments in texaphyrin chemistry and drug discovery.

@nl

prefLabel

Recent developments in texaphyrin chemistry and drug discovery.

@en

Recent developments in texaphyrin chemistry and drug discovery.

@nl

P1433

Q37659410-3530FFCA-E216-4063-BB49-DABFB1515A37

P1476

Q37659410-F869043D-A012-4C7F-9964-2790E1C7340C

P2093

Q37659410-0385F093-A154-4BCD-96AA-B52FC59EFA2B

Q37659410-48FBA7B1-F5B9-4ECB-8534-603FFD05A7D5

Q37659410-5D86D6CA-3CE4-4D01-80EA-98B1C4FF430B

Q37659410-6086C316-D830-43B4-B05D-25A18199F502

Q37659410-96C4726C-82B8-4890-ACA1-75500AC8D6CC

Q37659410-B6CA8AE6-07B0-4E52-BEE9-575161C543D5

Q37659410-B7846D77-BA71-4787-B14D-18143848207D

Q37659410-D7DC1F3A-D243-464B-B56D-C7962459CB5F

P2860

Q37659410-07ED39D8-2DA5-4982-AB6F-49C0928A449B

Q37659410-3015556A-A352-4DF0-BB50-BCE9FD345B37

Q37659410-3143AAC6-955C-4B28-9D09-80B5705519E3

Q37659410-34128F09-7419-4FAB-835E-3107760DCABA

Q37659410-3684EBF5-8283-4C63-AED1-1B1D3A57BEA6

Q37659410-388BECB7-EEB8-4D7C-9BBA-81A96975F4B3

Q37659410-400B1667-3D65-4D71-9A42-3D9E0E3386BB

Q37659410-4191A732-6FCE-43AA-945F-57E70E7B0DA8

Q37659410-475F447D-21E0-4372-8B81-4BE67AE155B7

Q37659410-485AE909-2219-4586-AD7A-781A3FFA3AC3

P304

Q37659410-E5B00CFD-53CD-4D9C-B021-901D5BA14FE8

P31

Q37659410-485FD47C-8D78-4EF1-A2EF-321A6E55B643

P356

Q37659410-F4B36526-65EA-4564-8847-5DA489B76C04

P407

Q37659410-618E603C-3FAA-4DD0-88DA-64D964EF8646

P433

Q37659410-2CC98425-F19C-4E74-9B9F-BEEF3251D3FB

P478

Q37659410-1E864BCC-5737-43B7-8C11-8048CA4925FF

P577

Q37659410-7D6FE2BD-2987-428B-8940-B5D4E3A1B57E

P698

Q37659410-9A7F3D72-F99B-4A45-B0F8-08D568188345

P932

Q37659410-D8CE0BAC-E291-41DF-AB2D-A6A48D91E15E

P356

P1433

Inorganic Chemistry

P1476

Recent developments in texaphyrin chemistry and drug discovery.

@en

P2093

Christian Preihs

http://www.w3.org/2001/XMLSchema#string

Darren Magda

http://www.w3.org/2001/XMLSchema#string

Dongwon Yoo

http://www.w3.org/2001/XMLSchema#string

Heeyeong Jeong

http://www.w3.org/2001/XMLSchema#string

Jinwoo Cheon

http://www.w3.org/2001/XMLSchema#string

Jonathan F Arambula

http://www.w3.org/2001/XMLSchema#string

Jonathan L Sessler

http://www.w3.org/2001/XMLSchema#string

Zahid H Siddik

http://www.w3.org/2001/XMLSchema#string

P2860

Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen

Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53

DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2

Cisplatin: mode of cytotoxic action and molecular basis of resistance

Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points.

Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.

The cellular response to p53: the decision between life and death.

Role of p53 in the ability of 1,2-diaminocyclohexane-diacetato-dichloro-Pt(IV) to circumvent cisplatin resistance.

Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.

Texaphyrins: new drugs with diverse clinical applications in radiation and photodynamic therapy.

P304

12184-12192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/IC400226G

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23557113

http://www.w3.org/2001/XMLSchema#string

P932

3963820

http://www.w3.org/2001/XMLSchema#string